European Innovation Solutions S.A. (ATH:EIS)

Market Cap	20.27M
Revenue (ttm)	4.94M
Net Income (ttm)	1.67M
Shares Out	15.33M
EPS (ttm)	0.11
PE Ratio	11.91
Forward PE	n/a
Dividend	0.04 (3.03%)
Ex-Dividend Date	Jul 7, 2025

Volume	69,941
Average Volume	82,104
Open	1.330
Previous Close	1.322
Day's Range	1.294 - 1.342
52-Week Range	1.250 - 1.380
Beta	0.40
RSI	43.77
Earnings Date	Sep 22, 2025

About Verve Therapeutics

European Innovation Solutions S.A. provides consulting services in Greece, Bulgaria, Kazakhstan, Cyprus, Czech Republic, Romania, Albania, and Croatia. It provides management consulting advises and implementation services; and transaction and finance advisory services, including finance strategy and operating model, finance excellence and SSC, controlling and performance management, modern ERP, treasury, compliance, regulatory reporting, and risk management. The company also offers investment planning and implementation services; and programme ...

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Founded: 1990
• Employees: 63
• Stock Exchange: Athens Stock Exchange
• Ticker Symbol: EIS

Financial Performance

In 2023, ATH:EIS's revenue was 5.07 million, an increase of 7.33% compared to the previous year's 4.72 million. Earnings were 2.06 million, an increase of 23.29%.